ARE vs AVGO Stock Comparison
Alexandria Real Estate Equities, Inc. vs Broadcom Inc.
ARE leads
ARE leads by 10 AIQ points, primarily on Momentum and Value, having only recently taken the lead back from AVGO. Wall Street currently favors AVGO on target upside.
Fragile: 3 of 6 evidence groups support ARE, the lead recently changed hands, and its signal state is cleanly positive.
Alexandria Real Estate Equities, Inc.
Broadcom Inc.
The Algovestiq AIQ Score currently favors ARE over AVGO, 57 versus 47 as of Sep 5, 2026. ARE's advantage is driven primarily by stronger momentum and value, while AVGO holds the stronger quality profile. ARE also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors AVGO. 3 of 6 covered evidence groups favor ARE today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. ARE lead: Reversed — AVGO led by 12 AIQ points 30 sessions ago; ARE now leads by 10.
Compare Alexandria Real Estate Equities, Inc. and Broadcom Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Compare ARE and AVGO against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum25%75 vs 20ARE +55
- Quality30%47 vs 85AVGO +38
- Value30%61 vs 30ARE +31
- Risk Resilience15%37 vs 52AVGO +15
3 of 6 evidence groups favor ARE. ARE’s edge is concentrated in momentum and value; AVGO keeps a meaningful quality edge.
What changed since the last close
Latest scored session 2026-09-03, compared against the prior scored session 2026-09-02.
Largest factor move: Momentum +1
No new signals fired.
Largest factor move: Momentum -1
New signals
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (3.79%)
ARE's lead widened by 2 AIQ points in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — ARE and AVGO both carry a full feed there.
The central trade-off
ARE (Alexandria Real Estate Equities, Inc.): the stronger current systematic profile, led by momentum and value.
AVGO (Broadcom Inc.): the counter-case, on quality, risk resilience, fundamentals.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
AREARE on the overall AIQ Score, which weights Quality and Value at 30% each.
Growth
AVGOAVGO on combined revenue and EPS growth.
Value
AREARE on the peer-relative Value factor, by 31 points.
Momentum
AREARE on the Momentum factor, by 55 points.
Lower downside
AVGOAVGO on Risk Resilience, by 15 points.
Analyst upside
AVGOAVGO on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors ARE, analyst targets favor AVGO. That disagreement is the most useful thing on this page.
| Measure | ARE | AVGO | Note |
|---|---|---|---|
| Implied upside to target | +0% | +40.1% | AVGO has more room |
| Target dispersion | +32.3% | +36.3% | Lower is tighter analyst agreement |
| Consensus | Hold | Buy | Context, not a primary driver |
| Analysts covering | 8 | 15 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor ARE. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | ARE | 57 vs 47 |
| Fundamentals | AVGOon balance | revenue growth 18.6% vs 14.9%; EPS growth -97.1% vs 26.5%; TTM ROE -5.7% vs 36.4%; gross margin 69.5% vs 67%; operating margin -45.7% vs 43.7% — AVGO takes 3 of 5 decided legs, not all of them |
| Valuation | ARE | Value 61 vs 30 |
| Technicals | ARE | Price vs 50-day 3.7% vs -6.8%; vs 200-day 5.1% vs -3.4% |
| Risk Resilience | AVGO | Risk Resilience 37 vs 52 |
| Analyst expectations | AVGO | Target upside 0% vs 40.1% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ARE and AVGO and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is moderate at 10 points.
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The lead has swung materially session to session. (argues the conclusion is provisional)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ARE.
How the comparison changed
120 daily snapshots · Apr 22 – Sep 3ARE lead: Reversed — AVGO led by 12 AIQ points 30 sessions ago; ARE now leads by 10.
- Today
- ARE +10
- 57 vs 47
- 7 sessions ago
- ARE +14
- 59 vs 45
- 30 sessions ago
- AVGO +12
- 50 vs 62
- 90 sessions ago
- ARE +5
- 54 vs 49
The lead changed hands 9 times in this window, most recently on Aug 19 when ARE moved ahead of AVGO.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
3 bullish / 0 bearish / 1 neutral
- Golden Cross Active — bullish, trend, long horizon (1.29%)
- Uptrend Structure Active — bullish, trend, long horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (3.57%)
2 bullish / 1 bearish / 1 neutral, conflicted
- Golden Cross Active — bullish, trend, long horizon (3.87%)
- RSI Oversold - Potential Bounce — bullish, momentum, short horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (3.79%)
AVGO is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.08%, AIQ +1 points).
Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +0.21%, AIQ -1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1AVGO closes the Momentum gap — currently 55 points behind, the largest single contributor to ARE's edge.
- 2AVGO's ATR Expansion - Breakout Mode turns directional — it is neutral today and would confirm a change in trend.
- 3ARE's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A regime shift changes factor weighting — the composite weights Quality and Value at 30% each, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
AVGO leads on balance| Metric | ARE | AVGO |
|---|---|---|
| Revenue growth (YoY) | 18.6% | 14.9% |
| EPS growth (YoY) | -97.1% | 26.5% |
| Gross margin | 69.5% | 67% |
| Operating margin | -45.7% | 43.7% |
| Return on equity (TTM) | -5.7% | 36.4% |
| Debt to equity | 0.85 | 0.74 |
Technicals
ARE has the stronger structure| Metric | ARE | AVGO |
|---|---|---|
| RSI (14) | 65.3 | 28.4 |
| ADX (14) | 17.2 | 22.7 |
| Price vs 50-day | 3.7% | -6.8% |
| Price vs 200-day | 5.1% | -3.4% |
| Volatility (1M, annualized) | 47% | 36.2% |
Risk
AVGO is the more resilient| Metric | ARE | AVGO |
|---|---|---|
| Beta | 0.52 | 2.15 |
| Sharpe ratio | -0.78 | 0.51 |
| Sortino ratio | -0.93 | 0.76 |
| Max drawdown | -53.8% | -28.9% |
| Current drawdown | -39.8% | -25.8% |
| Annualized volatility | 46.7% | 48.5% |
| Value at risk (95%) | -4.5% | -4.4% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, ARE or AVGO?
On the Algovestiq AIQ Score, ARE is the stronger of the two as of Sep 5, 2026, scoring 57 against AVGO's 47. The edge comes from momentum and value. AVGO is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is ARE or AVGO the better buy right now?
ARE carries the stronger systematic profile as of Sep 5, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.
Why does the AIQ Score favor ARE over AVGO?
The composite weights Quality at 30%, Value at 30%, Momentum at 25% and Risk Resilience at 15%. ARE leads Momentum by 55 points; AVGO leads Quality by 38 points; ARE leads Value by 31 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, ARE or AVGO?
Analyst price targets imply +0% upside for ARE and +40.1% for AVGO, so the Street currently favors AVGO. That points the opposite way to the AIQ Score, which favors ARE. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, ARE or AVGO?
ARE is the better-valued of the two on the peer-relative Value factor. ARE on the peer-relative Value factor, by 31 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, ARE or AVGO?
AVGO on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, ARE or AVGO?
ARE on the Momentum factor, by 55 points. Momentum carries 25% of the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, ARE or AVGO?
AVGO is the more resilient of the two, so the other name carries the higher downside risk. AVGO on Risk Resilience, by 15 points. The Risk Resilience factor weights 15% of the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is ARE more profitable than AVGO?
The profitability evidence is mixed: gross margin 69.5% vs 67%; operating margin -45.7% vs 43.7%; ttm roe -5.7% vs 36.4%. ARE leads on one measure and AVGO on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is ARE's lead over AVGO getting stronger or weaker?
ARE lead: Reversed — AVGO led by 12 AIQ points 30 sessions ago; ARE now leads by 10. This is measured from 120 daily comparison snapshots between 2026-04-22 and 2026-09-03. The lead has changed hands 9 times in that window, most recently on 2026-08-19, when ARE moved ahead of AVGO.
What would change the ARE vs AVGO verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AVGO closes the Momentum gap — currently 55 points behind, the largest single contributor to ARE's edge; AVGO's ATR Expansion - Breakout Mode turns directional — it is neutral today and would confirm a change in trend; ARE's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a regime shift changes factor weighting — the composite weights Quality and Value at 30% each, so a rotation toward either would move the result most.
What do the current signals say about ARE and AVGO?
ARE: 3 bullish / 0 bearish / 1 neutral. AVGO: 2 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ARE is Golden Cross Active (bullish, long horizon). On AVGO it is Golden Cross Active (bullish, long horizon).
Compare ARE and AVGO with others
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality (30%), Value (30%), Momentum (25%) and Risk (15%). Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.